UTAustinX: Effective Mathematical Thinking Through Mathematics: UT.9.01x About Video
[youtube http://www.youtube.com/watch?v=Kktxd5ECQu0&fs=1&rel=0] Effective Thinking Through Mathematics Learn tools of effective thinking through puzzles and the world of mathematics around you in this fun and fascinating … Video Rating: 4 / 5 [youtube http://www.youtube.com/watch?v=DCLfFejowHo&fs=1&rel=0] BBC 4 – Ancient math of Ethiopia amazing method of Mathematics calculation. Before even the computer they break the code it’s so […]
Security Industry Association to Host Securing New Ground in New York City
Silver Spring, Md. (PRWEB) September 04, 2014 The Security Industry Association (SIA) will host Securing New Ground® (SNG), the premiere executive conference in the security industry, on Oct. 29-30, 2014, at the Millennium Broadway Hotel in New York City. SIA recently updated the agenda for the conference online at http://www.securingnewground.com. By attending SNG, security suppliers […]
Mathematics: The Next Generation – Professor Peter Cameron
Mathematics is important to us all. So it is important to enable young mathematicians, clear-thinking and passionate about their subject, to contribute at th… This video is about great scientists of India whose contribution to mathematics is enormous, but this was rather ignored by westerners. http://www.indianmind… Video Rating: 4 / 5
HetNet Ecosystem Investments to Reach USD 20 Bln in 2020, Says Signals and Systems Telecom in Its New Study Published at MarketPublishers.com
London, UK (PRWEB) September 05, 2014 Small cells, carrier WiFi, DAS (distributed antenna systems) and C-RAN (cloud radio access networks) infrastructure is set to account for more than 50% of all mobile data traffic by 2015-end, whilst overall investments in the HetNet ecosystem are expected to amount to USD 20 billion in 2020. HetNet infrastructure […]
Vicus Therapeutics Announces Phase II Data Demonstrating Overall Survival Benefit with VT-122 Plus Sorafenib in Patients with Advanced Hepatocellular Carcinoma
MORRISTOWN, N.J (PRWEB) September 05, 2014 Vicus Therapeutics, an immuno-oncology company focused on bringing breakthrough immunotherapies to patients with solid-tumor cancers, announced positive results from a Phase II randomized, open-label, controlled clinical trial of its lead compound, VT-122, in combination with sorafenib, in patients with advanced hepatocellular carcinoma (HCC). In an intent-to-treat (ITT) population, investigators […]